These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6797934)

  • 21. Acute Trypanosoma cruzi infection differentially affects CD3 and Thy-1 mediated T cell activation.
    de Oliveira GA; Gattass CR
    Immunol Lett; 1991 Jun; 28(3):227-32. PubMed ID: 1679416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental autoimmune encephalomyelitis can be prevented and cured by infection with Trypanosoma cruzi.
    Tadokoro CE; Vallochi AL; Rios LS; Martins GA; Schlesinger D; Mosca T; Kuchroo VK; Rizzo LV; Abrahamsohn IA
    J Autoimmun; 2004 Sep; 23(2):103-15. PubMed ID: 15324929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trypanosoma cruzi-induced suppression of IL-2 production. I. Evidence for the presence of IL-2-producing cells.
    Tarleton RL
    J Immunol; 1988 Apr; 140(8):2763-8. PubMed ID: 2965729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trypanosoma cruzi: infection of T lymphocytes and their destruction by antibody-dependent cell-mediated cytotoxicity.
    Velge P; Kusnierz JP; Ouaissi A; Marty B; Pham BN; Capron A
    Eur J Immunol; 1991 Sep; 21(9):2145-52. PubMed ID: 1909643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations induced by Trypanosoma cruzi in activated mouse lymphocytes.
    Lopez HM; Tanner MK; Kierszenbaum F; Sztein MB
    Parasite Immunol; 1993 May; 15(5):273-80. PubMed ID: 8332383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease.
    Marinho CR; D'Império Lima MR; Grisotto MG; Alvarez JM
    Infect Immun; 1999 Jan; 67(1):308-18. PubMed ID: 9864231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed hypersensitivity to Trypanosoma cruzi in mice: specific suppressor cells in chronic infection.
    Scott MT
    Immunology; 1981 Oct; 44(2):409-17. PubMed ID: 6457792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modification of T-cell proliferation and interleukin 2 production in mice infected with Trypanosoma cruzi.
    Harel-Bellan A; Joskowicz M; Fradelizi D; Eisen H
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3466-9. PubMed ID: 6407015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spleen cell-mediated suppression of IgG production to a non-parasite antigen during chronic Trypanosoma cruzi infection in mice.
    Reed SG; Roters SB; Goidl EA
    J Immunol; 1983 Oct; 131(4):1978-82. PubMed ID: 6225801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppressive substance produced by T cells from mice chronically infected with Trypanosoma cruzi. I. Preferential inhibition of the induction of delayed-type hypersensitivity.
    Liew FY; Scott MT; Liu DS; Croft SL
    J Immunol; 1987 Oct; 139(7):2452-7. PubMed ID: 2958550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trypanosoma cruzi induces suppression of DNA synthesis and inhibits expression of interleukin-2 receptors by stimulated human B lymphocytes.
    Kierszenbaum F; Moretti E; Sztein MB
    Immunology; 1991 Oct; 74(2):317-22. PubMed ID: 1748480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenge of Trypanosoma cruzi chronically infected mice with trypomastigotes activates the immune system and reduces subpatent parasitemia levels.
    Marinho CR; Bastos KR; Sardinha LR; Grisotto MG; Lima MR; Alvarez JM
    J Parasitol; 2004 Jun; 90(3):516-23. PubMed ID: 15270095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trypanosoma cruzi-induced suppressor substance III. Activation of suppressor cells.
    Cunningham DS; Kuhn RE
    J Parasitol; 1980 Dec; 66(6):881-7. PubMed ID: 6452519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi.
    Tarleton RL
    J Immunol; 1990 Jan; 144(2):717-24. PubMed ID: 2104903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caspase inhibition reduces lymphocyte apoptosis and improves host immune responses to Trypanosoma cruzi infection.
    Silva EM; Guillermo LV; Ribeiro-Gomes FL; De Meis J; Nunes MP; Senra JF; Soares MB; DosReis GA; Lopes MF
    Eur J Immunol; 2007 Mar; 37(3):738-46. PubMed ID: 17295391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in the regulation of humoral responses between mice infected with Trypanosoma cruzi and mice administered T. cruzi-induced suppressor substance.
    Cunningham DS; Benavides GR; Kuhn RE
    J Immunol; 1980 Nov; 125(5):2317-21. PubMed ID: 6776190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time-dependent mode of immunization augments suppressed antibody responses in spleen cell cultures from mice experimentally infected with Trypanosoma cruzi.
    Choromanski L; Kuhn RE
    Int J Parasitol; 1989 Dec; 19(8):935-8. PubMed ID: 2517539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
    Fernández MC; González Cappa SM; Solana ME
    Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
    Basso B; Marini V
    Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant granulocyte-macrophage colony-stimulating factor restores deficient immune responses in mice with chronic Trypanosoma cruzi infections.
    Reed SG; Grabstein KH; Pihl DL; Morrissey PJ
    J Immunol; 1990 Sep; 145(5):1564-70. PubMed ID: 2117033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.